Phenotype and frequency of Epstein-Barr virus-infected cells in pretreatment blood samples from patients with Hodgkin lymphoma

British Journal of Haematology

Volumn 129, Issue 4, 2005, Pages 511-519

  Khan, Gulfaraz ^a,e   Lake, Annette ^a   Shield, Lesley ^a   Freeland, June ^a   Andrew, Linda ^a   Alexander, Freda E ^b   Jackson, Robert ^c   Taylor, Penelope R A ^d   McCruden, Elizabeth A B ^a   Jarrett, Ruth F ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

^d ROYAL VICTORIA INFIRMARY   (United Kingdom)

^e KINGSTON UNIVERSITY   (United Kingdom)

Author keywords

Epstein Barr virus; Hodgkin lymphoma; Memory B cell; Persistent infection; Polymerase chain reaction

Indexed keywords

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HODGKIN DISEASE; HUMAN; IN SITU HYBRIDIZATION; MALE; MEMORY CELL; PATHOGENESIS; PERSISTENT VIRUS INFECTION; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; B-LYMPHOCYTES; CHILD; FEMALE; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IMMUNOLOGIC MEMORY; IN SITU HYBRIDIZATION; INFECTIOUS MONONUCLEOSIS; LEUKOCYTES; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; VIRAL LOAD;

EID: 20044383960     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05483.x     Document Type: Article

References (54)

1. Alexander, F.E., Jarrett, R.F., Lawrence, D., Armstrong, A.A., Freeland, J., Gokhale, D.A., Kane, E., Taylor, G.M., Wright, D.H. & Cartwright, R.A. (2000) Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents. British Journal of Cancer, 82, 1117-1121.
2. Alexander, F.E., Jarrett, R.F., Cartwright, R.A., Armstrong, A.A., Gokhale, D.A., Kane, E., Gray, D., Lawrence, D.J. & Taylor, G.M. (2001) Epstein-Barr virus and HLA-DPB1-*301 in young adult Hodgkin's disease: evidence for inherited susceptibility to Epstein-Barr virus in cases that are EBV(+ve). Cancer Epidemiology, Biomarkers & Prevention, 10, 705-709.
3. Alexander, F.E., Lawrence, D.J., Freeland, J., Krajewski, A.S., Angus, B., Taylor, G.M. & Jarrett, R.F. (2003) An epidemiologic study of index and family infectious mononucleosis and adult Hodgkin's disease (HD): Evidence for a specific association with EBV+ve HD in young adults. International Journal of Cancer, 107, 298-302.
4. Araujo, I., Foss, H.D., Hummel, M., Anagnostopoulos, I., Barbosa, H.S., Bittencourt, A. & Stein, H. (1999) Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma. Journal of Pathology, 187, 326-330.
5. Armstrong, A.A., Alexander, F.E., Cartwright, R., Angus, B., Krajewski, A.S., Wright, D.H., Brown, I., Lee, F., Kane, E. & Jarrett, R.F. (1998) Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis. Leukemia, 12, 1272-1276.
6. Babcock, G.J. & Thorley-Lawson, D.A. (2000) Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors. Proceedings of the National Academy of Sciences of the United States of America, 97, 12250-12255.
7. Babcock, G.J., Decker, L.L., Volk, M. & Thorley-Lawson, D.A. (1998) EBV persistence in memory B cells in vivo. Immunity, 9, 395-404.
8. Babcock, G.J., Decker, L.L., Freeman, R.B. & Thorley-Lawson, D.A. (1999) Epstein-Barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. Journal of Experimental Medicine, 190, 567-576.
9. Babcock, G.J., Hochberg, D. & Thorley-Lawson, D.A. (2000) The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity, 13, 497-506.
10. Brauninger, A., Hansmann, M.L., Strickler, J.G., Dummer, R., Burg, G., Rajewsky, K. & Kuppers, R. (1999) Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. New England Journal of Medicine, 340, 1239-1247.
11. Graver, R.D., Scheer, W.D., Correa, H., Vehaskari, V.M. & Yu, L.C. (2001) Hodgkin lymphoma in a renal transplant recipient associated with low peripheral blood Epstein-Barr virus genome copies. Archives of Pathology & Laboratory Medicine, 125, 1480-1482.
12. Deacon, E.M., Pallesen, G., Niedobitek, G., Crocker, J., Brooks, L., Rickinson, A.B. & Young, L.S. (1993) Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. Journal of Experimental Medicine, 177, 339-349.
13. Douglas, A.S., Brown, T. & Reid, D. (1996) Infectious mononucleosis and Hodgkin's disease - a similar seasonality. Leukemia and Lymphoma, 23, 323-331.
14. Faumont, N., al Saati, T., Brousset, P., Offer, C., Delsol, G. & Meggetto, F. (2001) Demonstration by single-cell PCR that Reed-Sternberg cells and bystander B lymphocytes are infected by different Epstein-Barr virus strains in Hodgkin's disease. Journal of General Virology, 82, 1169-1174.
15. Gallagher, A., Perry, J., Freeland, J., Alexander, F.E., Carman, W.F., Shield, L., Cartwright, R. & Jarrett, R.F. (2003) Hodgkin lymphoma and Epstein-Barr virus (EBV): no evidence to support hit-and-run mechanism in cases classified as non-EBV-associated. International Journal of Cancer, 104, 624-630.
16. Glaser, S.L., Lin, R.J., Stewart, S.L., Ambinder, R.F., Jarrett, R.F., Brousset, P., Pallesen, G., Gulley, M.L., Khan, G., O'Grady, J., Hummel, M., Preciado, M.V., Knecht, H., Chan, J.K. & Claviez, A. (1997) Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. International Journal of Cancer, 70, 375-382.
17. Grasser, F.A., Murray, P.G., Kremmer, E., Klein, K., Remberger, K., Feiden, W., Reynolds, G., Niedobitek, G., Young, L.S. & Mueller-Lantzsch, N. (1994) Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease. Blood, 84, 3792-3798.
18. Gruss, H.J., Pinto, A., Duyster, J., Poppema, S. & Herrmann, F. (1997) Hodgkin's disease: a tumor with disturbed immunological pathways. Immunology Today, 18, 156-163.
19. Hjalgrim, H., Askling, J., Rostgaard, K., Hamilton-Dutoit, S., Frisch, M., Zhang, J.S., Madsen, M., Rosdahl, N., Konradsen, H.B., Storm, H.H. & Melbye, M. (2003) Characteristics of Hodgkin's lymphoma after infectious mononucleosis. New England Journal of Medicine, 349, 1324-1332.
20. Hochberg, D., Middeldorp, J.M., Catalina, M., Sullivan, J.L., Luzuriaga, K. & Thorley-Lawson, D.A. (2004a) Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proceedings of the National Academy of Sciences of the United States of America, 101, 239-244.
21. Hochberg, D., Souza, T., Catalina, M., Sullivan, J.L., Luzuriaga, K. & Thorley-Lawson, D.A. (2004b) Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells. Journal of Virology, 78, 5194-5204.
22. IARC (1997) Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8. Lyon, France, 17-24 June 1997. IARC Monographs on the Evaluation of Carcinogenic risk to Humans, 70, 1-492.
23. Jarrett, R.F. (1998) Epstein-Barr virus and Hodgkin's disease. Epstein-Barr Virus Report, 5, 77-85.
24. Jarrett, R.F. (2002) Viruses and Hodgkin's lymphoma. Annals of Oncology, 13(Suppl. 1), 23-29.
25. Jarrett, R.F., Armstrong, A.A. & Alexander, E. (1996) Epidemiology of EBV and Hodgkin's lymphoma. Annals of Oncology, 7, S5-S10.
26. Joseph, A.M., Babcock, G.J. & Thorley-Lawson, D.A. (2000) Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils. Journal of Virology, 74, 9964-9971.
27. Kanzler, H., Kuppers, R., Hansmann, M.L. & Rajewsky, K. (1996) Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. Journal of Experimental Medicine, 184, 1495-1505.
28. Khan, G., Miyashita, E.M., Yang, B., Babcock, G.J. & Thorley-Lawson, D.A. (1996) Is EBV persistence in vivo a model for B cell homeostasis? Immunity, 5, 173-179.
29. Klein, U., Rajewsky, K. & Kuppers, R. (1998) Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. Journal of Experimental Medicine, 188, 1679-1689.
30. Kuppers, R. & Rajewsky, K. (1998) The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease. Annual Review of Immunology, 16, 471-493.
31. Kuppers, R., Rajewsky, K., Zhao, M., Simons, G., Laumann, R., Fischer, R. & Hansmann, M.L. (1994) Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proceedings of the National Academy of Sciences of the United States of America, 91, 10962-10966.
32. Kuppers, R., Sousa, A.B., Baur, A.S., Strickler, J.G., Rajewsky, K. & Hansmann, M.L. (2001) Common germinal-center B-cell origin of the malignant cells in two composite lymphomas, involving classical Hodgkin's disease and either follicular lymphoma or B-CLL. Molecular Medicine, 7, 285-292.
33. Kurth, J., Spieker, T., Wustrow, J., Strickler, G.J., Hansmann, L.M., Rajewsky, K. & Kuppers, R. (2000) EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency. Immunity, 13, 485-495.
34. Lucas, K.G., Burton, R.L., Zimmerman, S.E., Wang, J., Cornetta, K.G., Robertson, K.A., Lee, C.H. & Emanuel, D.J. (1998) Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood, 91, 3654-3661.
35. MacKenzie, J., Gallagher, A., Clayton, R.A., Perry, J., Eden, O.B., Ford, A.M., Greaves, M.F. & Jarrett, R.F. (2001) Screening for herpesvirus genomes in common acute lymphoblastic leukemia. Leukemia, 15, 415-421.
36. Marafioti, T., Hummel, M., Anagnostopoulos, I., Foss, H.D., Huhn, D. & Stein, H. (1999) Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell. Journal of Clinical Oncology, 17, 3804-3809.
37. Miyashita, E.M., Yang, B., Lam, K.M., Crawford, D.H. & Thorley-Lawson, D.A. (1995) A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell, 80, 593-601.
38. Newell, G.R., Lynch, H.K., Gibeau, J.M. & Spitz, M.R. (1985) Seasonal diagnosis of Hodgkin's disease among young adults. Journal of the National Cancer Institute, 74, 53-56.
39. Niedobitek, G., Kremmer, E., Herbst, H., Whitehead, L., Dawson, C.W., Niedobitek, E., von Ostau, C., Rooney, N., Grasser, F.A. & Young, L.S. (1997) Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis. Blood, 90, 1664-1672.
40. Pallesen, G., Hamilton-Dutoit, S.J., Rowe, M. & Young, L.S. (1991) Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet, 337, 320-322.
41. Reiman, A., Powell, J.E., Flavell, K.J., Grundy, R.G., Mann, J.R., Parkes, S., Redfern, D., Young, L.S. & Murray, P.G. (2003) Seasonal differences in the onset of the EBV-positive and -negative forms of paediatric Hodgkin's lymphoma. British Journal of Cancer, 89, 1200-1201.
42. Rickinson, A.B. & Kieff, E. (2001) Epstein-Barr virus. In: Fields Virology (ed. by D. M. Knipe & P.M. Howley), pp. 2575-2627. Lippincott Williams & Wilkins, Philadelphia, PA.
43. Rowe, M., Lear, A.L., Croom-Carter, D., Davies, A.H. & Rickinson, A.B. (1992) Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. Journal of Virology, 66, 122-131.
44. Spieker, T., Kurth, J., Kuppers, R., Rajewsky, K., Brauninger, A. & Hansmann, M.L. (2000) Molecular single-cell analysis of the clonal relationship of small Epstein-Barr virus-infected cells and Epstein-Barr virus-harboring Hodgkin and Reed/Sternberg cells in Hodgkin disease. Blood, 96, 3133-3138.
45. Starzl, T.E., Nalesnik, M.A., Porter, K.A., Ho, M., Iwatsuki, S., Griffith, B.P., Rosenthal, J.T., Hakala, T.R., Shaw, Jr, B.W. & Hardesty, R.L. (1984) Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet, 1, 583-587.
46. (ed. by E.S. Jaffe, N.L. Harris, H. Stein & J.W. Vardiman). Stein, H. (2001) Hodgkin lymphomas: introduction. In: World Health Organisation Classification of Tumours: Pathology and Genetics of Tumours of Hematopoietic Lymphoid Tissues (ed. by E.S. Jaffe, N.L. Harris, H. Stein & J.W. Vardiman), pp. 238-239. IARC, Lyon, France.
47. Stein, H., Delsol, G., Pileri, S., Said, J., Mann, R., Poppema, S., Swerdlow, S.H. & Jaffe, E.S. (2001) Classical Hodgkin lymphoma. In: World Health Organisation Classification of Tumours: Pathology and Genetics of Tumours of Hematopoietic Lymphoid Tissues (ed. by E.S. Jaffe, N.L. Harris, H. Stein & J.W. Vardiman), pp. 244-253. IARC, Lyon, France.
48. Stevens, S.J., Verschuuren, E.A., Pronk, I., van Der, B.W., Harmsen, M.C., The, T.H., Meijer, C.J., van den Brule, A.J. & Middeldorp, J.M. (2001) Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of post-transplant lymphoproliferative disease in high-risk patients. Blood, 97, 1165-1171.
49. Thorley-Lawson, D.A. (2001) Epstein-Barr virus: exploiting the immune system. Nature Reviews Immunology, 1, 75-82.
50. Thorley-Lawson, D.A. & Gross, A. (2004) Persistence of the Epstein-Barr virus and the origins of associated lymphomas. New England Journal of Medicine, 350, 1328-1337.
51. Thorley-Lawson, D.A., Miyashita, E.M. & Khan, G. (1996) Epstein-Barr virus and the B cell: that's all it takes. Trends in Microbiology, 4, 204-208.
52. Williams, D.A. (1975) The analysis of binary responses from toxicological experiments involving reproduction and teratogenicity. Biometrics, 31, 949-952.
53. Wu, T.C., Mann, R.B., Charache, P., Hayward, S.D., Staal, S., Lambe, B.C. & Ambinder, R.F. (1990) Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease. International Journal of Cancer, 46, 801-804.
54. Young, L., Alfieri, C., Hennessy, K., Evans, H., O'Hara, C., Anderson, K.C., Ritz, J., Shapiro, R.S., Rickinson, A., Kieff, E. & Cohen, J.I. (1989) Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. New England Journal of Medicine, 321, 1080-1085.